| 标题 |
Risk-dependent Benefit of Adjuvant Pembrolizumab in High-risk Clear Cell Renal Cell Carcinoma: A Multi-institutional Study |
| 网址 | |
| DOI |
10.1016/j.euo.2026.08.004.Onlineaheadofprint
doi
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)